Antitumor Activity of HM781-36B, alone or in Combination with Chemotherapeutic Agents, in Colorectal Cancer Cells.
Kang, Mi Hyun
Antitumor Activity of HM781-36B, alone or in Combination with Chemotherapeutic Agents, in Colorectal Cancer Cells. [electronic resource] - Cancer research and treatment Jan 2016 - 355-64 p. digital
Publication Type: Journal Article
2005-9256
10.4143/crt.2014.260 doi
Antineoplastic Agents--administration & dosage
Apoptosis--drug effects
Camptothecin--analogs & derivatives
Cell Line, Tumor
Cell Survival--drug effects
Colorectal Neoplasms--drug therapy
Drug Synergism
ErbB Receptors--antagonists & inhibitors
Extracellular Signal-Regulated MAP Kinases--metabolism
Fluorouracil--pharmacology
G1 Phase Cell Cycle Checkpoints--drug effects
Humans
Irinotecan
Organoplatinum Compounds--pharmacology
Oxaliplatin
Protein Biosynthesis--drug effects
Protein-Tyrosine Kinases--antagonists & inhibitors
Proto-Oncogene Proteins c-akt--metabolism
Quinazolines--administration & dosage
Antitumor Activity of HM781-36B, alone or in Combination with Chemotherapeutic Agents, in Colorectal Cancer Cells. [electronic resource] - Cancer research and treatment Jan 2016 - 355-64 p. digital
Publication Type: Journal Article
2005-9256
10.4143/crt.2014.260 doi
Antineoplastic Agents--administration & dosage
Apoptosis--drug effects
Camptothecin--analogs & derivatives
Cell Line, Tumor
Cell Survival--drug effects
Colorectal Neoplasms--drug therapy
Drug Synergism
ErbB Receptors--antagonists & inhibitors
Extracellular Signal-Regulated MAP Kinases--metabolism
Fluorouracil--pharmacology
G1 Phase Cell Cycle Checkpoints--drug effects
Humans
Irinotecan
Organoplatinum Compounds--pharmacology
Oxaliplatin
Protein Biosynthesis--drug effects
Protein-Tyrosine Kinases--antagonists & inhibitors
Proto-Oncogene Proteins c-akt--metabolism
Quinazolines--administration & dosage